Aegerion Pharmaceuticals, Inc.
101 Main Street
Suite 1850
Cambridge
Massachusetts
02142
United States
Tel: 617-500-7867
Fax: 908-541-1155
Website: http://www.aegerion.com/
Email: info@aegerion.com
219 articles about Aegerion Pharmaceuticals, Inc.
-
Tarveda Therapeutics Appoints Jeffrey Bloss, M.D. as Chief Medical Officer
9/12/2018
Steven Hamburger, Ph.D. appointed as Vice President, Regulatory Affairs and Laura Mei appointed as Vice President, Clinical Operations.
-
There have been a number of leadership changes in biotech companies over the last week. BioSpace has put together a list of new c-suite level hires and position changes.
-
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals
1/31/2018
Financial terms of the sentence align with previous company filings.
-
Novelion Therapeutics Provides Update on Agreement Between Aegerion Pharmaceuticals and U.S. Department of Justice
11/21/2017
The Company, in consultation with its outside counsel, is currently evaluating its options and next steps.
-
Criminal And Civil Actions Filed Against Aegerion
9/25/2017
-
Aegerion, A Subsidiary Of Novelion, Enters Into Agreement In Principle To Settle Class Action Shareholder Lawsuit
12/5/2016
-
Veristat Strengthens Its Long-Standing Relationship With Aegerion By Establishing A Preferred Provider Agreement
9/19/2016
-
Aegerion Announces Second Quarter 2016 Financial Results
8/10/2016
-
Struggling Aegerion Axes 13% of Workforce, Withdraws Cholesterol Drug from the EU
7/21/2016
-
Update In Lawsuit For Investors In Aegerion Shares Announced By Shareholders Foundation
6/21/2016
-
Aegerion CEO on Company's Long Road and Its Fresh Start Post-Merger
6/17/2016
-
Beleaguered Cambridge Drugmaker Aegerion Merges with QLT to Survive
6/15/2016
-
Aegerion Announces First Quarter 2016 Financial Results
5/17/2016
-
Aegerion Observes Rare Disease Day
2/29/2016
-
Aegerion Announces Fourth Quarter And Full Year 2015 Financial Results
2/26/2016
-
Facing Tough Competition from Regeneron and Amgen, Aegerion Slashes 25% of Workforce
2/12/2016
-
Aegerion Release: JUXTAPID (Lomitapide) Capsules Available On The Régie De l'Assurance Maladie Du Québec (RAMQ) For The Treatment Of Homozygous Familial Hypercholesterolemia (HoFH)
11/20/2015
-
Aegerion Observes Familial Hypercholesterolemia Awareness Day
9/24/2015
-
Aegerion Announces Presentation At The Leerink Rare Disease Roundtable
9/24/2015
-
Donald K. Stern, Esq. Appointed To Aegerion' Board Of Directors
9/18/2015